Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
about
Neural correlates of the LSD experience revealed by multimodal neuroimagingLysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.PsychedelicsModern Clinical Research on LSD.Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Neuropharmacology of N,N-dimethyltryptamineClinical applications of hallucinogens: A review.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Novel psychoactive substances of interest for psychiatry.Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.Serotonin and brain function: a tale of two receptorsDreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.5-HT2A Agonists: A Novel Therapy for Functional Neurological Disorders?Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.Effect of Hallucinogens on Unconditioned Behavior.Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.Positive regulation of raphe serotonin neurons by serotonin 2B receptors.Unifying Theories of Psychedelic Drug Effects.Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.Ebselen has lithium-like effects on central 5-HT2A receptor function."Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.An Argument for Amphetamine-Induced Hallucinations in an Invertebrate.Psychedelika: An ancient sacrament for treatment of contemporary psychiatric illness?Psychedelics, Meditation, and Self-Consciousness
P2860
Q24174843-372AA963-1A4F-4814-BBCD-2E0F2CF5F776Q26746133-34503EC9-262A-4EE9-A4FD-388606DF5570Q26746137-F4468822-416C-4A73-80BE-4D4CA9A67153Q30358201-FACCCB2E-4162-4D5D-A2F0-CE377AB7CCD8Q30359998-AC39DC20-CCF4-4687-ADCC-F26FD0760C8CQ30401421-108ED5A6-39CA-4FAC-9890-1CAEDBB376AFQ30402789-D110A77B-59D5-437F-9889-48C27B62DE75Q30843010-33768A13-0FC6-4FBF-937C-5CF4839EDE13Q33577499-A18D42B0-FADF-4E72-AED7-43461C9FCF4CQ33881804-39F3A0F9-344B-4A92-8640-AF3E4810AA3BQ34497649-985FF40F-EFC4-4FE6-99DC-00EAB1CBD468Q34524116-28F13CEB-FC9F-4B80-8A7D-DD6E1514E79EQ34535259-B39A108B-9BA1-41C8-A0D7-5B6F998EDCB1Q34546304-26B42DE9-AE41-48AD-83DB-C43D6888DEE5Q34667835-A79CC541-7168-4663-BA0B-F0FD16E0A936Q35024752-DC2B5EF1-D684-40CC-BABF-A4A53993F665Q36844764-36DE25B2-EA2D-4C53-A3AD-3AB1736B9472Q37306537-522116C4-B1B1-4CCE-A0D3-7270E3D4729EQ38600048-9A6FA41C-9EB2-49A8-9579-A067B90EF10DQ38733778-2CDF0933-7E90-414A-A7C7-1217F301EB58Q38794300-86FD23E4-1975-4061-A21A-FA38FA7D1404Q39093171-220855BD-D62A-43E2-987A-E11916D5A9A8Q39370168-617164C4-C418-4DEF-96D6-45D0CA9FE092Q39414464-9BDE283D-6BB9-473C-B29E-5031EAB5B913Q39834312-493FB6AC-98E1-4CD4-9BD9-4CD00F42BECAQ40717603-E14A385D-0E9F-4E4F-9BF3-C10A8E8983F2Q41842170-E6C2D58F-2144-43F8-8A0E-9103B11A0DDCQ42025447-5A9C96D3-1D4D-46B7-A6C6-CB41DB842C86Q45279141-F8B13D1D-C189-4EBD-A7B3-494EFE90FF45Q46573497-3DAE2A94-9022-4983-BD7A-2CB9AD377384Q47690853-325C94C0-B84A-4F20-8C48-163B8D98C148Q49912053-65BCDF14-5A97-48A4-ADA3-CC266C7B62DDQ52641641-E9D7D26A-4200-4D00-8625-DB38B42376B1Q53080749-698731AA-05ED-480E-9683-19C671D4226FQ53445382-8E150D61-CC77-4E46-A28A-462357710A5EQ55058151-DF486489-E6CC-4AF9-AA37-5465719C80E1Q55516348-A7268CCC-E771-40EE-83E5-3D80C19B90ABQ56638625-1DEE7BC1-71CD-4D29-B212-EC6135BBF9ADQ56852531-F45C67E9-5550-4F34-B4EA-58D3DA25849CQ58764595-2A254862-503E-4A31-9E56-2D4360E1F1E7
P2860
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@ast
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@en
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@nl
type
label
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@ast
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@en
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@nl
prefLabel
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@ast
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@en
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@nl
P2860
P3181
P1476
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
@en
P2093
Adam L Halberstadt
P2860
P304
P3181
P356
10.1016/J.BBR.2014.07.016
P407
P577
2014-07-15T00:00:00Z